PTC Therapeutics
Email page Email Page  Print Page Print Page  Contact Us   Text Size
A  A  A
 Leadership
 Senior Management
Stuart W. Peltz, Ph.D.
William Baird, III
Neil Almstead, Ph.D.
Kurt Andrews
John Babiak, Ph.D.
Mark E. Boulding
Joseph M. Colacino, Ph.D.
Cláudia Hirawat
Clare Kennedy
Manal Morsy, M.D., Ph.D.
Theresa Natalicchio
 Board of Directors
 Scientific Advisory Board
 Collaborations
 Working at PTC
Manal Morsy, M.D., Ph.D.

Vice President, Regulatory
Prior to joining PTC as Vice President of Regulatory in June 2007, Dr. Morsy spent three years at Tibotec, a Johnson & Johnson company, most recently serving as Senior Director, Global Regulatory Affairs. There she was responsible for global regulatory activities for the company's tuberculosis program and pediatric development programs. Previous to her tenure at Tibotec, Dr. Morsy served as Director of Worldwide Regulatory Affairs for Merck & Co., where she supported new regulatory filings in the US and abroad, as well as supplemental filings for previously approved products.

Dr. Morsy received her medical degree at the Alexandria University Faculty of Medicine and residency training in pediatrics and genetics at the Cairo National Research Center, her Ph.D. in Biomedical Sciences and Molecular Biology from the Eastern Virginia Medical School, and her MBA from the Drexel University, Le Bow College of Business. Dr. Morsy is the first author of numerous peer-reviewed publications, including those published in Journal of Clinical Investigation, Nature Biotechnology, Proceedings of the National Academy of Sciences, and Journal of the American Medical Association.

Manal Morsy, M.D., Ph.D.